Patent Expiry

Patent/Exclusivity Expiry: HALAVEN

Other upcoming events for INTS

Phase 3 ReadoutPhase 3 Topline: A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Adminis

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: HALAVEN — INTS Patent Expiry | BioSniper